We have previously shown that low dose transdermal estrogen pre-treatment selectively reduced inflammatory cytokines in women with obesity accompanied by an increase in LH pulse amplitude and GnRH stimulated FSH [4]. The gene discussed is PLOD1; the disease is obesity due to melanocortin 4 receptor deficiency.